DXCM Stock - DexCom Inc.

DXCM Stock Chart

DXCM Profile

DexCom, Inc., headquartered in San Diego, California, specializes in the advancement of medical devices focused on continuous glucose monitoring (CGM) systems, catering to both domestic and international markets. Founded in 1999, the company is dedicated to designing, developing, and commercializing innovative solutions aimed at enhancing the management of diabetes.

Central to DexCom's product portfolio is the Dexcom G6, an integrated CGM system renowned for its accuracy and ease of use in diabetes management. The company also offers Dexcom Real-Time API, enabling third-party developers to seamlessly integrate real-time CGM data into various digital health applications and devices, thereby fostering enhanced patient monitoring and treatment outcomes.

In addition to its flagship products, DexCom provides Dexcom ONE, a system designed to replace traditional finger stick blood glucose testing for making critical diabetes treatment decisions, and Dexcom Share, a remote monitoring system that enhances patient care through continuous glucose data sharing. Anticipated innovations include the Dexcom G7 CGM system, representing the next generation of DexCom's cutting-edge technology.

DexCom, Inc. collaborates extensively within the healthcare industry, including a significant partnership and license agreement with Verily Life Sciences LLC and Verily Ireland Limited. This collaboration aims to develop advanced blood-based or interstitial glucose monitoring products, underscoring DexCom's commitment to driving technological advancements in diabetes care and management.

DXCM Revenue Chart

DXCM Earnings

Analyst Ratings